Stevanato group to create manufacturing hub in china

Piombino dese, italy--(business wire)--stevanato group (nyse: stvn) (the “company”), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the acquisition of a facility in zhangjiagang for a new plant where the company expects to begin renovations in the spring 2022, as part of the latest phase of its expansion in china. the new facility is located near the company's drug containment solut
STVN Ratings Summary
STVN Quant Ranking